Boxed Warning on risk of severe hypocalcaemia with denosumab

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 1992卷 / 1期

关键词：

D O I：

10.1007/s40278-024-52736-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[41] Boxed warning added to intrathecal baclofen
Reactions Weekly, 2002, 904 (1) : 2 - 2
[42] New Boxed Warning for Osteoporosis Drug
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2024, 124 (06) : 19 - 19
[43] A Boxed Warning for Inadequate Psoriasis Treatment
Kagha, Karen C.
Blauvelt, Andrew
Anderson, Kathryn L.
Leonardi, Craig L.
Feldman, Steven R.
CUTIS, 2016, 98 (03): : 206 - 207
[44] Salmeterol: boxed warning added in US
Reactions Weekly, 2003, 965 (1) : 2 - 2
[45] FDA approves Multaq with a boxed warning
Reactions Weekly, 2009, 1260 (1) : 3 - 3
[46] TGA provides boxed warning guidance
Reactions Weekly, 2018, 1732 (1) : 7 - 7
[47] DIABETES DRUG RECEIVES BOXED WARNING FOR INCREASED RISK OF LEG AND FOOT AMPUTATIONS
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2017, 117 (09) : 22 - 23
[48] Safety card and boxed warning for abacavir
Reactions Weekly, 1998, 729 (1) : 2 - 2
[49] FDA in favour of boxed warning for Xolair
Reactions Weekly, 2007, 1141 (1) : 4 - 4
[50] Warning of an increased risk of vertebral fracture after stopping denosumab
Symonds, Christopher
Kline, Gregory
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (16) : E485 - E486

← 1 2 3 4 5 →